Genetic data will be safeguarded with 23andMe sale, drugmaker vows – The Washington Post

Business News

  1. Genetic data will be safeguarded with 23andMe sale, drugmaker vows  The Washington Post
  2. Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale  GlobeNewswire
  3. 23andMe To Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million  The New York Times
  4. Struggling DNA testing firm 23andMe to be bought for $256m  BBC
  5. Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million  WSJ

Source: Business News